Policies and programmes
Policy
We recognise that there may be instances when it is appropriate for healthcare professionals to seek an unapproved vaccine or medicine for treatment use for a patient where no satisfactory alternatives exist. Our policy and programmes may provide an option for providers and patients faced with these challenges.
Healthcare professional requests for compassionate use
If you are a healthcare professional who would like to request compassionate use of a GSK investigational medicine for a patient, please use the GSK Compassionate Use Request Portal. You will need to create a profile before you can submit your request.
To manage your enquiry, we are required to record and maintain the personal information you have provided us with, including your name and contact details. This personal information will be processed solely for the purpose of dealing with your enquiry. More detailed information on the processing of your personal information is available from our Privacy Notice.
Patient requests for compassionate use
If you are a patient and would like to make a request for compassionate use of a GSK investigational medicine, please contact your personal healthcare professional.
Importation of Unlicensed Medicines programme
The Importation of Unlicensed Medicines programme may provide a legal route for a physician to treat a patient with a GSK medication that has been approved in a major market, but that has not yet approved in their country for the same indication.
Patient eligibility for these treatments includes:
- Serious or life-threatening disease
- No alternative treatments available
- Inability to participate in a clinical trial
Requesting use of an unlicensed GSK medicine
- For oncology, please email MedicineAccess@Clinigengroup.com
- For any other request please connect with your local GSK entity - search our local markets contact details directory
